0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Irritable Bowel Syndrome Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-22H5855
Home | Market Reports | Health| Health Conditions
Global Irritable Bowel Syndrome Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Irritable Bowel Syndrome Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-22H5855
Report
September 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Irritable Bowel Syndrome Treatment - Market Size

The global market for Irritable Bowel Syndrome Treatment was estimated to be worth US$ 4737.2 million in 2023 and is forecast to a readjusted size of US$ 6127.9 million by 2030 with a CAGR of 3.8% during the forecast period 2024-2030

Irritable Bowel Syndrome Treatment - Market

Irritable Bowel Syndrome Treatment - Market

Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in decreasing the symptoms.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Irritable Bowel Syndrome Treatment by region & country, by Type, and by Application.
The Irritable Bowel Syndrome Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome Treatment.
Market Segmentation

Scope of Irritable Bowel Syndrome Treatment - Market Report

Report Metric Details
Report Name Irritable Bowel Syndrome Treatment - Market
Forecasted market size in 2030 US$ 6127.9 million
CAGR 3.8%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Hospitals
  • Clinics
  • Homecare Settings
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bausch Health, Sucampo Pharmaceuticals, Abbott Laboratories, Lexicon Pharmaceuticals, Salix Pharmaceuticals, Ironwood Pharmaceuticals, GlaxoSmithKline, Allergan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Irritable Bowel Syndrome Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Irritable Bowel Syndrome Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Irritable Bowel Syndrome Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Irritable Bowel Syndrome Treatment - Market size in 2030?

Ans: The Irritable Bowel Syndrome Treatment - Market size in 2030 will be US$ 6127.9 million.

Who are the main players in the Irritable Bowel Syndrome Treatment - Market report?

Ans: The main players in the Irritable Bowel Syndrome Treatment - Market are Bausch Health, Sucampo Pharmaceuticals, Abbott Laboratories, Lexicon Pharmaceuticals, Salix Pharmaceuticals, Ironwood Pharmaceuticals, GlaxoSmithKline, Allergan

What are the Application segmentation covered in the Irritable Bowel Syndrome Treatment - Market report?

Ans: The Applications covered in the Irritable Bowel Syndrome Treatment - Market report are Hospitals, Clinics, Homecare Settings

What are the Type segmentation covered in the Irritable Bowel Syndrome Treatment - Market report?

Ans: The Types covered in the Irritable Bowel Syndrome Treatment - Market report are Irritable Bowel Syndrome with Constipation, Irritable Bowel Syndrome with Diarrhea, Irritable Bowel Syndrome with alternating Constipationand Diarrhea

Recommended Reports

Gastrointestinal Disorders

Pain & Chronic Conditions

Neurological & Psychological

1 Market Overview
1.1 Irritable Bowel Syndrome Treatment Product Introduction
1.2 Global Irritable Bowel Syndrome Treatment Market Size Forecast
1.3 Irritable Bowel Syndrome Treatment Market Trends & Drivers
1.3.1 Irritable Bowel Syndrome Treatment Industry Trends
1.3.2 Irritable Bowel Syndrome Treatment Market Drivers & Opportunity
1.3.3 Irritable Bowel Syndrome Treatment Market Challenges
1.3.4 Irritable Bowel Syndrome Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Irritable Bowel Syndrome Treatment Players Revenue Ranking (2023)
2.2 Global Irritable Bowel Syndrome Treatment Revenue by Company (2019-2024)
2.3 Key Companies Irritable Bowel Syndrome Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Irritable Bowel Syndrome Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Irritable Bowel Syndrome Treatment
2.6 Irritable Bowel Syndrome Treatment Market Competitive Analysis
2.6.1 Irritable Bowel Syndrome Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Irritable Bowel Syndrome Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Irritable Bowel Syndrome with Constipation
3.1.2 Irritable Bowel Syndrome with Diarrhea
3.1.3 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
3.2 Global Irritable Bowel Syndrome Treatment Sales Value by Type
3.2.1 Global Irritable Bowel Syndrome Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Irritable Bowel Syndrome Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Irritable Bowel Syndrome Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Homecare Settings
4.2 Global Irritable Bowel Syndrome Treatment Sales Value by Application
4.2.1 Global Irritable Bowel Syndrome Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Irritable Bowel Syndrome Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Irritable Bowel Syndrome Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Irritable Bowel Syndrome Treatment Sales Value by Region
5.1.1 Global Irritable Bowel Syndrome Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Irritable Bowel Syndrome Treatment Sales Value by Region (2019-2024)
5.1.3 Global Irritable Bowel Syndrome Treatment Sales Value by Region (2025-2030)
5.1.4 Global Irritable Bowel Syndrome Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Irritable Bowel Syndrome Treatment Sales Value, 2019-2030
5.2.2 North America Irritable Bowel Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Irritable Bowel Syndrome Treatment Sales Value, 2019-2030
5.3.2 Europe Irritable Bowel Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Irritable Bowel Syndrome Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Irritable Bowel Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Irritable Bowel Syndrome Treatment Sales Value, 2019-2030
5.5.2 South America Irritable Bowel Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Irritable Bowel Syndrome Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Irritable Bowel Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Irritable Bowel Syndrome Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Irritable Bowel Syndrome Treatment Sales Value
6.3 United States
6.3.1 United States Irritable Bowel Syndrome Treatment Sales Value, 2019-2030
6.3.2 United States Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Irritable Bowel Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Irritable Bowel Syndrome Treatment Sales Value, 2019-2030
6.4.2 Europe Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Irritable Bowel Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Irritable Bowel Syndrome Treatment Sales Value, 2019-2030
6.5.2 China Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Irritable Bowel Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Irritable Bowel Syndrome Treatment Sales Value, 2019-2030
6.6.2 Japan Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Irritable Bowel Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Irritable Bowel Syndrome Treatment Sales Value, 2019-2030
6.7.2 South Korea Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Irritable Bowel Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Irritable Bowel Syndrome Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Irritable Bowel Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Irritable Bowel Syndrome Treatment Sales Value, 2019-2030
6.9.2 India Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Irritable Bowel Syndrome Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bausch Health
7.1.1 Bausch Health Profile
7.1.2 Bausch Health Main Business
7.1.3 Bausch Health Irritable Bowel Syndrome Treatment Products, Services and Solutions
7.1.4 Bausch Health Irritable Bowel Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Bausch Health Recent Developments
7.2 Sucampo Pharmaceuticals
7.2.1 Sucampo Pharmaceuticals Profile
7.2.2 Sucampo Pharmaceuticals Main Business
7.2.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Products, Services and Solutions
7.2.4 Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Sucampo Pharmaceuticals Recent Developments
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Profile
7.3.2 Abbott Laboratories Main Business
7.3.3 Abbott Laboratories Irritable Bowel Syndrome Treatment Products, Services and Solutions
7.3.4 Abbott Laboratories Irritable Bowel Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Lexicon Pharmaceuticals Recent Developments
7.4 Lexicon Pharmaceuticals
7.4.1 Lexicon Pharmaceuticals Profile
7.4.2 Lexicon Pharmaceuticals Main Business
7.4.3 Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Products, Services and Solutions
7.4.4 Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Lexicon Pharmaceuticals Recent Developments
7.5 Salix Pharmaceuticals
7.5.1 Salix Pharmaceuticals Profile
7.5.2 Salix Pharmaceuticals Main Business
7.5.3 Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Products, Services and Solutions
7.5.4 Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Salix Pharmaceuticals Recent Developments
7.6 Ironwood Pharmaceuticals
7.6.1 Ironwood Pharmaceuticals Profile
7.6.2 Ironwood Pharmaceuticals Main Business
7.6.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Products, Services and Solutions
7.6.4 Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Ironwood Pharmaceuticals Recent Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Profile
7.7.2 GlaxoSmithKline Main Business
7.7.3 GlaxoSmithKline Irritable Bowel Syndrome Treatment Products, Services and Solutions
7.7.4 GlaxoSmithKline Irritable Bowel Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 GlaxoSmithKline Recent Developments
7.8 Allergan
7.8.1 Allergan Profile
7.8.2 Allergan Main Business
7.8.3 Allergan Irritable Bowel Syndrome Treatment Products, Services and Solutions
7.8.4 Allergan Irritable Bowel Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Allergan Recent Developments
8 Industry Chain Analysis
8.1 Irritable Bowel Syndrome Treatment Industrial Chain
8.2 Irritable Bowel Syndrome Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Irritable Bowel Syndrome Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Irritable Bowel Syndrome Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Irritable Bowel Syndrome Treatment Market Trends
    Table 2. Irritable Bowel Syndrome Treatment Market Drivers & Opportunity
    Table 3. Irritable Bowel Syndrome Treatment Market Challenges
    Table 4. Irritable Bowel Syndrome Treatment Market Restraints
    Table 5. Global Irritable Bowel Syndrome Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Irritable Bowel Syndrome Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Irritable Bowel Syndrome Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Irritable Bowel Syndrome Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Irritable Bowel Syndrome Treatment
    Table 10. Global Irritable Bowel Syndrome Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Irritable Bowel Syndrome Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Irritable Bowel Syndrome Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Irritable Bowel Syndrome Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Irritable Bowel Syndrome Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Irritable Bowel Syndrome Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Irritable Bowel Syndrome Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Irritable Bowel Syndrome Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Irritable Bowel Syndrome Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Irritable Bowel Syndrome Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Irritable Bowel Syndrome Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Irritable Bowel Syndrome Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Irritable Bowel Syndrome Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Irritable Bowel Syndrome Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Irritable Bowel Syndrome Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Irritable Bowel Syndrome Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Irritable Bowel Syndrome Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Irritable Bowel Syndrome Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Irritable Bowel Syndrome Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Bausch Health Basic Information List
    Table 32. Bausch Health Description and Business Overview
    Table 33. Bausch Health Irritable Bowel Syndrome Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Business of Bausch Health (2019-2024)
    Table 35. Bausch Health Recent Developments
    Table 36. Sucampo Pharmaceuticals Basic Information List
    Table 37. Sucampo Pharmaceuticals Description and Business Overview
    Table 38. Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Business of Sucampo Pharmaceuticals (2019-2024)
    Table 40. Sucampo Pharmaceuticals Recent Developments
    Table 41. Abbott Laboratories Basic Information List
    Table 42. Abbott Laboratories Description and Business Overview
    Table 43. Abbott Laboratories Irritable Bowel Syndrome Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Business of Abbott Laboratories (2019-2024)
    Table 45. Abbott Laboratories Recent Developments
    Table 46. Lexicon Pharmaceuticals Basic Information List
    Table 47. Lexicon Pharmaceuticals Description and Business Overview
    Table 48. Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Business of Lexicon Pharmaceuticals (2019-2024)
    Table 50. Lexicon Pharmaceuticals Recent Developments
    Table 51. Salix Pharmaceuticals Basic Information List
    Table 52. Salix Pharmaceuticals Description and Business Overview
    Table 53. Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Business of Salix Pharmaceuticals (2019-2024)
    Table 55. Salix Pharmaceuticals Recent Developments
    Table 56. Ironwood Pharmaceuticals Basic Information List
    Table 57. Ironwood Pharmaceuticals Description and Business Overview
    Table 58. Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Business of Ironwood Pharmaceuticals (2019-2024)
    Table 60. Ironwood Pharmaceuticals Recent Developments
    Table 61. GlaxoSmithKline Basic Information List
    Table 62. GlaxoSmithKline Description and Business Overview
    Table 63. GlaxoSmithKline Irritable Bowel Syndrome Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Business of GlaxoSmithKline (2019-2024)
    Table 65. GlaxoSmithKline Recent Developments
    Table 66. Allergan Basic Information List
    Table 67. Allergan Description and Business Overview
    Table 68. Allergan Irritable Bowel Syndrome Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Irritable Bowel Syndrome Treatment Business of Allergan (2019-2024)
    Table 70. Allergan Recent Developments
    Table 71. Key Raw Materials Lists
    Table 72. Raw Materials Key Suppliers Lists
    Table 73. Irritable Bowel Syndrome Treatment Downstream Customers
    Table 74. Irritable Bowel Syndrome Treatment Distributors List
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
    Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Irritable Bowel Syndrome Treatment Product Picture
    Figure 2. Global Irritable Bowel Syndrome Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Irritable Bowel Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Irritable Bowel Syndrome Treatment Report Years Considered
    Figure 5. Global Irritable Bowel Syndrome Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Irritable Bowel Syndrome Treatment Revenue in 2023
    Figure 7. Irritable Bowel Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Irritable Bowel Syndrome with Constipation Picture
    Figure 9. Irritable Bowel Syndrome with Diarrhea Picture
    Figure 10. Irritable Bowel Syndrome with alternating Constipationand Diarrhea Picture
    Figure 11. Global Irritable Bowel Syndrome Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Irritable Bowel Syndrome Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospitals
    Figure 14. Product Picture of Clinics
    Figure 15. Product Picture of Homecare Settings
    Figure 16. Global Irritable Bowel Syndrome Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Irritable Bowel Syndrome Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Irritable Bowel Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Irritable Bowel Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Irritable Bowel Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Irritable Bowel Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Irritable Bowel Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Irritable Bowel Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Irritable Bowel Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Irritable Bowel Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Irritable Bowel Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Irritable Bowel Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Irritable Bowel Syndrome Treatment Sales Value (%), (2019-2030)
    Figure 29. United States Irritable Bowel Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Irritable Bowel Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Irritable Bowel Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Irritable Bowel Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Irritable Bowel Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Irritable Bowel Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Irritable Bowel Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Irritable Bowel Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Irritable Bowel Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Irritable Bowel Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Irritable Bowel Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Irritable Bowel Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Irritable Bowel Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Irritable Bowel Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Irritable Bowel Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 50. Irritable Bowel Syndrome Treatment Industrial Chain
    Figure 51. Irritable Bowel Syndrome Treatment Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart